U.S., Sept. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07830732) titled 'A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A' on Sept. 15.
Brief Summary: The purpose of this study is to find out if denecimig is safe and effective for treating people who have acquired haemophilia A. Participants will be in this study for up to around 1 year and 5 months (73 week).
Study Start Date: Oct. 09
Study Type: INTERVENTIONAL
Condition:
Haemophilia A
Intervention:
DRUG: Denecimig
Participants will receive subcutaneous (s.c.) injections of denecimig.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Novo Nordisk A/S
Published by HT Digital Content Services with permission f...